MD

Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc. is classed by the SEC under Services-Hospitals (industry code 8060), based in Sunrise, FL. Its latest filed balance sheet (2025-12-31) shows total assets of $2.1 billion (its filed statements).

Usage business Services-Hospitals Sunrise, FL filings since 1996 9 of 9 filed

Sector peers: AVAHCONCHENHC

4.1/10headline grade
vs its business-model standard

Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a usage business: prior from its industry code (SEC 8060, Services-Hospitals); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.

The grade, in three tenses

Headline 4.1 out of ten, 9 of 9 metrics filed: past 3.1 out of ten, present 3.8 out of ten, future 5.6 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.

The nine metrics

  • Surviving crises (past): 3.2 out of ten. 1 warning event since 2017; the latest 2020-12-21. 32nd percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Track record (past): 1.6 out of ten. -5.5% a year over 10 filed years; profitable in 6 of 10. 16th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Shareholder treatment (past): 6.1 out of ten. Share count grew 0.5% a year. 15% of cash flow returned. Insiders: 4 sales, 0 purchases. 61st percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Financial health (present): 5.4 out of ten. ROE 19%: 19¢ of profit per shareholder dollar. Leverage 61%: owes 61¢ per asset dollar. 54th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Industry position (present): 3.3 out of ten. bottom 33% of 22 in its family; net margin 8.6%. 33rd percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Leadership (present): 2.4 out of ten. bottom 24% of 19 in its family for leadership; chief executive since 2025. 24th percentile among 19 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
  • Room to expand (future): 8.3 out of ten. top 17% of 22 in its family for room to expand. 83rd percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Growth drivers (future): 3.6 out of ten. bottom 36% of 22 in its family for growth drivers. 36th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
  • Expectations vs reality (future): 6.4 out of ten. top 36% of 22 in its family for expectations against reality. 64th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).

The filing record

Newest annual report: Form 10-K filed 2026-02-19 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-04 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-04 (on EDGAR). Newest filing: Form 144, 2026-09-14. Filings on record since 1996. Read from EDGAR 2026-10-12.

Where the revenue comes from

Product and service lines in fiscal 2025: Health Care Patient Service 85%, Hospitals Contracts 14%, Product and Service Other 1%. As tagged in its annual report (Form 10-K, filed 2026-02-19).

Who runs it

Ordan, Mark S (Chief Executive Officer); Rossi, Kasandra H (EVP, CFO and Treasurer); Moore, Mary Ann E (EVP, GC, Chief Admin Off & Sec); Neeb, Don Gregory (EVP, Chief Invest & Strategy); Haddock, David (EVP, GC & Corp Sec); Linynsky, Laura A (director); Young, Sylvia Jean (director); Mceachin, Thomas (director); Newman, Kurt Douglas (director); Rucker, Michael A. (director); and 3 more. 13 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.

This file: Overview · Past · Present · Future · Filings · every company on file

Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.